The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss

International Journal of Obesity

Volumn 36, Issue 9, 2012, Pages 1195-1202

  Veum, V L ^a,b   Dankel, S N ^a,b   Gjerde, J ^a,b   Nielsen, H J ^c   Solsvik, M H ^a,b   Haugen, C ^b   Christensen, B J ^a,b   Hoang, T ^a,b   Fadnes, D J ^d   Busch, C ^e   Vge, V ^d   Sagen, J V ^a,b   Mellgren, G ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Voss Hospital   (Norway)

^d Section for Rheumatology   (Norway)

^e Klinikk Bergen   (Norway)

Author keywords

adipose tissue; gene expression; nuclear receptors; stromal vascular fraction

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR RECEPTOR NOR1; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CASE CONTROL STUDY; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HERNIORRHAPHY; HUMAN; IN VITRO STUDY; INTRAABDOMINAL FAT; LAPAROSCOPIC SURGERY; LAPAROTOMY; MALE; MICROARRAY ANALYSIS; OBESITY; OMENTUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; SLEEVE GASTRECTOMY; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; NORWAY; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; OBESITY, MORBID; PROSPECTIVE STUDIES; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION; WEIGHT LOSS;

EID: 84866368209     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.240     Document Type: Article

References (44)

1. Iozzo P. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care 2009; 32(Suppl 2): S168-S173.
2. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008; 6: 343-368.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867. (Pubitemid 46024993)
4. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
5. McKenna NJ, O'Malley BW. SnapShot: nuclear receptors I. Cell 2010; 142: 822-822.e1.
6. McKenna NJ, O'Malley BW. SnapShot: nuclear receptors II. Cell 2010; 142: 986.e1.
7. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294: 1866-1870. (Pubitemid 33101573)
8. Sonoda J, Pei L, Evans RM. Nuclear receptors: decoding metabolic disease. FEBS Letters 2008; 582: 2-9. (Pubitemid 350297241)
9. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev 2007; 28: 575-587. (Pubitemid 47236337)
10. O'Malley BW, McKenna NJ. Coactivators and corepressors: what's in a name? Mol Endocrinol 2008; 22: 2213-2214.
11. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C et al. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism 2007; 56: 267-279. (Pubitemid 46084934)
12. Fang C, Yoon S, Tindberg N, Jarvelainen HA, Lindros KO, Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem Pharmacol 2004; 67: 1389-1397. (Pubitemid 38315104)
13. Maruyama K, Tsukada T, Ohkura N, Bandoh S, Hosono T, Yamaguchi K. The NGFI-B subfamily of the nuclear receptor superfamily (review). Int J Oncol 1998; 12: 1237-1243.
14. Pearen MA, Muscat GEO. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 2010; 24: 1891-1903.
15. Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 2006; 4: e002.
16. van Tiel CM, de Vries CJM. NR4All in the vessel wall. J Steroid Biochem Mol Biol 2011; e-pub ahead of print 26 January 2011.
17. Zhao Y, Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 2010; 30: 1535-1541.
18. Pols TW, Bonta PI, de Vries CJ. NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol 2007; 18: 515-520. (Pubitemid 47462203)
19. McMorrow JP, Murphy EP. Inflammation: a role for NR4A orphan nuclear receptors? Biochem Soc Trans 2011; 39: 688-693.
20. Maira M, Martens C, Batsche E, Gauthier Y, Drouin J. Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol 2003; 23: 763-776. (Pubitemid 36133496)
21. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995; 9: 769-782.
22. Dankel SN, Fadnes DJ, Stavrum AK, Stansberg C, Holdhus R, Hoang T et al. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One 2010; 5: e11033.
23. van Harmelen V, Skurk T, Hauner H. Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 2005; 107: 125-135.
24. Fu Y, Luo L, Luo N, Zhu X, Garvey WT. NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 2007; 282: 31525-31533. (Pubitemid 350044839)
25. Au WS, Payne VA, O'Rahilly S, Rochford JJ. The NR4A family of orphan nuclear receptors are not required for adipogenesis. Int J Obes (Lond) 2008; 32: 388-392. (Pubitemid 351271795)
26. Chao LC, Bensinger SJ, Villanueva CJ, Wroblewski K, Tontonoz P. Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. Mol Endocrinol 2008; 22: 2596-2608.
27. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247. (Pubitemid 46997129)
28. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M et al. Insulin sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299: E506-E515.
29. Yamashita S, Tanaka Y, Tsutsumi S, Aburatani H, Minato N, Ihara S. Analysis of mechanism for human gammadelta T cell recognition of nonpeptide antigens. Biochem Biophys Res Commun 2005; 334: 349-360. (Pubitemid 40982375)
30. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 2005; 280: 12573-12584.
31. Pei L, Castrillo A, Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 2006; 20: 786-794.
32. Dalmas E, Clement K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 2011; 32: 307-314.
33. Kim BY, Kim H, Cho EJ, Youn HD. Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation. Exp Mol Med 2008; 40: 71-83. (Pubitemid 351346819)
34. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009; 68: 370-377.
35. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009; 29: 4467-4483.
36. Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008; 100: 227-235.
37. Oita RC, Mazzatti DJ, Lim FL, Powell JR, Merry BJ. Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats. Mech Ageing Dev 2009; 130: 240-247.
38. Pols TW, Ottenhoff R, Vos M, Levels JH, Quax PH, Meijers JC et al. Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 2008; 366: 910-916.
39. Kolehmainen M, Vidal H, Alhava E, Uusitupa MI. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001; 9: 706-712. (Pubitemid 33603885)
40. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006; 12: 1048-1055. (Pubitemid 44353386)
41. Kumar N, Liu D, Wang H, Robidoux J, Collins S. Orphan nuclear receptor NOR-1 enhances 30,50-cyclic adenosine 50-monophosphate-dependent uncoupling protein-gene transcription. Mol Endocrinol 2008; 22: 1057-1064. (Pubitemid 351629607)
42. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM et al. A nuclear receptor Atlas: 3T3-L1 adipogenesis. Mol Endocrinol 2005; 19: 2437-2450. (Pubitemid 41362659)
43. Martinez-Gonzalez J, Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 2005; 65: 609-618. (Pubitemid 40138981)
44. Tanabe Y, Koga M, Saito M, Matsunaga Y, Nakayama K. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J Cell Sci 2004; 117 (Part 16): 3605-3614. (Pubitemid 39206400)